uniQure N.V. QURE
Key Stats
- Today's Range
- $43.90 – $45.48
- 50-Day Range
- $24.39 – $50.47
- 52-Week Range
- $8.73 – $71.50
- Volume
- 1.27 million shs
- Average Volume
- 1.63 million shs
- Market Cap
- $3.07 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.47%
- Days to Cover
- 2.44
About uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Related Stocks
Compare head-to-head: QURE vs LLY·QURE vs JNJ·QURE vs ABBV·QURE vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.